Bart Scott Selected Research

Bart Scott Research Topics

7	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 03/2022 - 12/2005
2	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2022 - 04/2014
2	Primary Myelofibrosis (Myelosclerosis) 12/2020 - 01/2006
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 04/2014 - 11/2013
2	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 01/2006 - 09/2005
2	Refractory Anemia 12/2005 - 11/2004
2	Refractory Anemia with Excess of Blasts (RAEM) 12/2005 - 11/2004
1	T-Cell Prolymphocytic Leukemia (Leukemia, T Cell, Chronic) 01/2022
1	Thrombocytopenia (Thrombopenia) 11/2012
1	Stroke (Strokes) 11/2012
1	Fibrosis (Cirrhosis) 01/2006
1	Myeloproliferative Disorders (Myeloproliferative Disorder) 01/2006
1	B-Cell Leukemia (Leukemia, B Cell) 12/2005

1	Biological ProductsIBA 10/2021
1	11- (2- pyrrolidin- 1- ylethoxy)- 14,19- dioxa- 5,7,26- triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa- 1(25),2(26),3,5,8,10,12(27),16,21,23- decaeneIBA 12/2020
1	tosedostatIBA 01/2016
1	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2016
1	Decitabine FDA Link 01/2016
1	Methotrexate (Mexate)FDA LinkGeneric 04/2014
1	fludarabineIBA 04/2014
1	treosulfanIBA 04/2014
1	Tacrolimus (Prograf)FDA LinkGeneric 04/2014
1	romiplostim FDA Link 11/2012
1	Lenalidomide (CC 5013)FDA Link 11/2012
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2005
1	NF-kappa B (NF-kB)IBA 12/2005
1	EnzymesIBA 12/2005
1	Arsenic Trioxide (Trisenox)FDA Link 12/2005
1	Proteins (Proteins, Gene)FDA Link 12/2005
1	CASP8 and FADD-Like Apoptosis Regulating Protein (FLIP-S)IBA 12/2005
1	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 11/2004
1	Etanercept (Enbrel)FDA Link 11/2004

7	Cell Transplantation 03/2022 - 09/2005
3	Therapeutics 10/2021 - 01/2006
1	Donor Selection 03/2022
1	MDC protocol 01/2022
1	Drug Tapering 11/2012
1	Transplantation 01/2006
1	Homologous Transplantation 01/2006